Immunotherapy for malignant disease.
D000328:Adult; D000818:Animals; D000951:Antigens, Neoplasm; D001500:BCG Vaccine / Q000009:adverse effects / Q000627:therapeutic use*; D003110:Colonic Neoplasms / Q000628:therapy; D006801:Humans; D007167:Immunotherapy / Q000009:adverse effects; D007945:Leukemia, Lymphoid / Q000628:therapy; D015470:Leukemia, Myeloid, Acute / Q000628:therapy; D008175:Lung Neoplasms / Q000628:therapy; D008545:Melanoma / Q000628:therapy; D009369:Neoplasms / Q000628:therapy*; D014613:Vaccines, Attenuated
D000951:Antigens, Neoplasm; D001500:BCG Vaccine; D014613:Vaccines, Attenuated